PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[conix]

I agree..."The recent dilution so close to the PDUFA was a giant red flag. If management had confidence in approval they would have waited just a few months for the milestone payments, or if necessary, wait to sell more shares at a far higher stock price. "

Perhaps I should have been more specific that it was the lack of transparency and dilution immediately prior to the clinical trial results. It was a red flag.

The positive viewpoint is that because of the capital raise, they now have the cash on hand to survive for their next move.

I would look for some consolidation at these lower levels as those investors that are disappointed sell... and the biotech gamblers come in.

As I mentioned before, there are a number of examples where being patient has rewarded long term investors. NOTE...BTX ONPH, OCGN and CTYX.